[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "10\u00b5g, 1, day 0, IM;3-6 months after the second dose of 2-dose regimen of inactive vaccine (BBIBP-CorV or CoronaVac).", "treatment_id": 1086, "treatment_name": "Recombinant sars-cov-2 fusion protein vaccine (v-01)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "3-6 months after the second dose of 2-dose regimen of inactive vaccine (BBIBP-CorV or CoronaVac).", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]